1. Home
  2. OVID vs SPRU Comparison

OVID vs SPRU Comparison

Compare OVID & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • SPRU
  • Stock Information
  • Founded
  • OVID 2014
  • SPRU 2008
  • Country
  • OVID United States
  • SPRU United States
  • Employees
  • OVID N/A
  • SPRU N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • SPRU Auto Parts:O.E.M.
  • Sector
  • OVID Health Care
  • SPRU Consumer Discretionary
  • Exchange
  • OVID Nasdaq
  • SPRU Nasdaq
  • Market Cap
  • OVID 47.1M
  • SPRU 46.9M
  • IPO Year
  • OVID 2017
  • SPRU N/A
  • Fundamental
  • Price
  • OVID $0.62
  • SPRU $2.52
  • Analyst Decision
  • OVID Strong Buy
  • SPRU
  • Analyst Count
  • OVID 6
  • SPRU 0
  • Target Price
  • OVID $4.03
  • SPRU N/A
  • AVG Volume (30 Days)
  • OVID 467.5K
  • SPRU 24.6K
  • Earning Date
  • OVID 03-07-2025
  • SPRU 03-13-2025
  • Dividend Yield
  • OVID N/A
  • SPRU N/A
  • EPS Growth
  • OVID N/A
  • SPRU N/A
  • EPS
  • OVID N/A
  • SPRU N/A
  • Revenue
  • OVID $631,695.00
  • SPRU $77,582,000.00
  • Revenue This Year
  • OVID $71.38
  • SPRU $1.54
  • Revenue Next Year
  • OVID N/A
  • SPRU $3.40
  • P/E Ratio
  • OVID N/A
  • SPRU N/A
  • Revenue Growth
  • OVID 113.21
  • SPRU N/A
  • 52 Week Low
  • OVID $0.56
  • SPRU $2.17
  • 52 Week High
  • OVID $3.79
  • SPRU $4.89
  • Technical
  • Relative Strength Index (RSI)
  • OVID 38.62
  • SPRU 39.94
  • Support Level
  • OVID $0.56
  • SPRU $2.44
  • Resistance Level
  • OVID $0.67
  • SPRU $2.65
  • Average True Range (ATR)
  • OVID 0.06
  • SPRU 0.12
  • MACD
  • OVID 0.00
  • SPRU 0.00
  • Stochastic Oscillator
  • OVID 35.94
  • SPRU 27.53

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is a leading owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to approximately 75,000 home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's primary customers are homeowners and the Company's core solar service offerings generate revenues primarily through (i) the sale of electricity generated by its home solar energy systems to homeowners, (ii) third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and (iii) the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: